Trending



Rwanda Drafts Harm Reduction Guidelines for People Who Inject Drugs

harm reduction in rwanda hiv prevention health centre kigali community healthcare worker
Written byMuiz Adeyemi EshinlokunFrontend Engineer and Content Lead, Computer Science (ND, HND)
Last updated 13 October 2026How we write and check this information

KIGALI, RWANDA — Public health authorities in Rwanda are drafting national harm reduction guidelines aimed at expanding access to HIV prevention, overdose response, and mental health services for people who inject drugs. Developed with technical support from the Rwanda Biomedical Centre (RBC) and civil society organizations under the TUBITEHO Project, the proposed framework seeks to address persistent healthcare gaps driven by social stigma and criminalization.

Speaking at a stakeholder validation meeting in Kigali, Dr. Zephanie Nzeyimana, HIV Key Population Strategic Officer at the RBC, emphasized that harm reduction interventions focus on mitigating direct health risks among vulnerable groups while integrating them into national health systems.

Epidemiological Profile and Harm Reduction in Rwanda

Surveillance metrics disclosed by public health agencies highlight significant HIV prevalence disparities between key populations and the general public:

Indicator Category National Metrics & Key Population Data
HIV Prevalence Gap

11.2% prevalence among people who inject drugs vs. 2.2% general population

Mapped Key Population

3,339 people who inject drugs identified nationwide (1,443 in Kigali)

High-Risk Behaviors

91% report sharing needles; 43% know someone who died of an overdose

National HIV Benchmark

Rwanda achieved UNAIDS 95-95-95 targets by December 2024

Service Delivery and Harm Reduction in Rwanda

To close remaining transmission gaps and reach UNAIDS targets, the draft framework establishes key operational mechanisms for harm reduction in rwanda:

  • Needle and Syringe Services: Distributing sterile injection equipment to reduce blood-borne transmission of HIV and Hepatitis C.

  • Opioid Substitution Therapy: Integrating medication-assisted treatments, such as methadone, and distributing naloxone for emergency overdose reversal.

  • Integrated Mental Health: Linking addiction management with community mental health services to address co-occurring substance use disorders.

Stigma, UNAIDS Targets, and Health System Equity

Rwanda reached the UNAIDS 95-95-95 benchmark for HIV diagnosis, treatment, and viral suppression in late 2024. However, remaining viral transmission chains are heavily concentrated among marginalized key populations. Fear of legal prosecution, social discrimination, and healthcare worker bias frequently deter individuals who inject drugs from seeking routine clinical care, diagnostic testing, or pre-exposure prophylaxis (PrEP).

Furthermore, mental health data indicates a substantial burden of psychological disorders across the general population, compounding vulnerability to substance use disorders. By involving community organizations of people who use drugs directly in policy design, health authorities aim to establish non-judgmental care pathways that encourage early health-seeking behavior and ensure equitable access to life-saving interventions.

Why It Matters: HIV prevalence is five times higher among Rwandans who inject drugs; implementing formal harm reduction guidelines closes critical coverage gaps to sustain national HIV epidemic control.

Source:The New Times (Rwanda) Report via allAfrica, October 12, 2026

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *